0001181431-12-042132.txt : 20120725
0001181431-12-042132.hdr.sgml : 20120725
20120725181611
ACCESSION NUMBER: 0001181431-12-042132
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120529
FILED AS OF DATE: 20120725
DATE AS OF CHANGE: 20120725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gionco David
CENTRAL INDEX KEY: 0001456864
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12979717
MAIL ADDRESS:
STREET 1: 9 HOWELL DRIVE
CITY: FAR HILLS
STATE: NJ
ZIP: 07931
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
3
1
rrd351641.xml
X0206
3
2012-05-29
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001456864
Gionco David
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER, 14TH FLOOR
EAST BRUNSWICK
NJ
08816
0
1
0
0
Group VP & Chief Acct Officer
Common Stock, $.01 par value
53488
D
Option to Purchase Common Stock, $.01 par value
4.32
2010-06-26
2016-06-26
Common Stock, $.01 par value
7500
D
Option to Purchase Common Stock, $.01 par value
4.53
2012-12-19
2018-12-19
Common Stock, $.01 par value
26000
D
Option to Purchase Common Stock, $.01 par value
5.27
2013-02-19
2019-02-19
Common Stock, $.01 par value
60000
D
Option to Purchase Common Stock, $.01 par value
13.81
2010-09-14
2019-11-22
Common Stock, $.01 par value
14582
D
Option to Purchase Common Stock, $.01 par value
9.63
2013-02-22
2021-02-22
Common Stock, $.01 par value
60000
D
These options are fully vested and exercisable.
19,500 of these options are fully vested and exercisable and 6,500 of these options will vest on December 19, 2012.
45,000 of these options are fully vested and exercisable and 15,000 of these options will vest on February 19, 2013.
15,000 of these options are fully vested and exercisable and 15,000 of these options will vest on each of February 22, 2013, February 22, 2014 and February 22, 2015.
Irina Ishak as Attorney-in-Fact for David Gionco
2012-07-25